TARDIVE DYSKINESIA
Clinical trials for TARDIVE DYSKINESIA explained in plain language.
Never miss a new study
Get alerted when new TARDIVE DYSKINESIA trials appear
Sign up with your email to follow new studies for TARDIVE DYSKINESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for tardive dyskinesia: tetrabenazine put to the test
Disease control CompletedThis study tested the drug tetrabenazine (Xenazine) in 54 adults with tardive dyskinesia, a condition causing uncontrollable movements after long-term antipsychotic use. The goal was to see if the drug could reduce these movements better than a placebo over 10 weeks. The approach…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for uncontrollable movements: valbenazine shows promise in TD study
Symptom relief CompletedThis study looked at how well valbenazine works for tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to long-term use of certain mental health medications. Fifty-nine adults with schizophrenia, bipolar disorder, or major depression took valbenazi…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC
-
New drug shows promise for calming uncontrollable body movements
Symptom relief CompletedThis study tested a daily pill called MT-5199 to see if it could reduce symptoms of tardive dyskinesia, a condition that causes uncontrollable movements of the face, mouth, arms, legs, and trunk. The study involved 256 adults with moderate to severe tardive dyskinesia who also ha…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE2, PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC